Skip to main content

Table 3 Posthospitalization treatments and outcomes

From: Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective study

 

Whole sample

(%)

Scheduled

outpatient visits (%)

Emergency

presentations (%)

n

96

50

46

Treatment

 Steroids

62 (64.6)

33 (66.0)

29 (63.0)

 Steroids and immunosuppressive

4 (4.2)

2 (4.0)

2 (4.3)

 Hormone supplementation

16 (16.7)

7 (14.0)

9 (19.6)

Outcome

 Resume administration of ICI

32 (33.3)

15 (30.0)

17 (37.0)

 Discontinue administration of ICI

53 (55.2)

30 (58.0)

23 (52.2)

 Death subsequent to hospitalization

8 (8.3)

4 (8.0)

4 (8.7)

 Other

3 (3.1)

2 (4.0)

1 (2.2)

  1. The placement of Table 3 is on page 15, after Treatment and outcome
  2. Abbreviations: ICI Immune checkpoint inhibitor